Cytosorbents CORP (CTSO) — 8-K Filings

All 8-K filings from Cytosorbents CORP. Browse 39 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (39)

8-K Filing — Apr 2, 2026
8-K Filing — Nov 13, 2025
Cytosorbents Corp Faces Delisting Concerns — Oct 3, 2025 Risk: high
Cytosorbents Corporation filed an 8-K on October 3, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a tran
Cytosorbents Corp. Files 8-K with Regulatory Updates — Sep 16, 2025 Risk: low
Cytosorbents Corp. filed an 8-K on September 16, 2025, reporting on various events. The filing includes information related to Regulation FD disclosures, other
Cytosorbents Corp Files 8-K on Other Events — Aug 20, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on August 20, 2025, reporting an event that occurred on August 14, 2025. The filing pertains to 'Other Events' and 'Financ
Cytosorbents Corp. Completes Asset Acquisition/Disposition — Aug 7, 2025 Risk: medium
Cytosorbents Corp. announced on August 7, 2025, the completion of an acquisition or disposition of assets. The filing does not specify the nature of the transac
Cytosorbents Corp Files 8-K — Aug 1, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on July 31, 2025, reporting other events and financial statements. The filing details the company's corporate structure, i
Cytosorbents Corp Files 8-K — Jul 2, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on July 2, 2025, reporting other events and financial statements. The filing does not contain specific details about the n
Cytosorbents Corp Files 8-K — Jun 24, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on June 24, 2025, reporting other events and financial statements. The filing does not contain specific details on new eve
Cytosorbents Corp Files 8-K on Security Holder Vote — Jun 13, 2025 Risk: low
Cytosorbents Corporation announced on June 12, 2025, that it is submitting matters to a vote of its security holders. The company, incorporated in Delaware with
Cytosorbents Corp Files 8-K: Regulation FD Disclosure — Jun 11, 2025 Risk: low
Cytosorbents Corporation announced on June 10, 2025, a Regulation FD Disclosure. The filing does not contain specific financial figures or new material events b
Cytosorbents Corp Files 8-K on Operations and Financials — May 14, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on May 14, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhib
Cytosorbents Corp Files 8-K with Financials — May 1, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on May 1, 2025, reporting events as of April 25, 2025. The filing primarily concerns financial statements and exhibits, wi
Cytosorbents Corp Files 8-K — Apr 17, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on April 17, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
Cytosorbents Corp Files 8-K — Apr 15, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on April 15, 2025, reporting an event on April 14, 2025. The filing is categorized under Regulation FD Disclosure and Fina
Cytosorbents Corp Files 8-K: Other Events & Financials — Apr 4, 2025 Risk: low
On April 4, 2025, Cytosorbents Corporation filed an 8-K report detailing other events and financial statements. The company, formerly known as MedaSorb Technolo
Cytosorbents Corp. Withdraws Prior Financial Statements — Mar 31, 2025 Risk: high
Cytosorbents Corporation announced on March 25, 2025, that it will not rely on previously issued financial statements. This decision impacts financial reporting
Cytosorbents Corp Files 8-K on Financials — Mar 21, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on March 21, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD
Cytosorbents Corp Files 8-K on Financials — Mar 4, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on March 4, 2025, reporting on its results of operations and financial condition, as well as providing Regulation FD discl
Cytosorbents Corp Files 8-K — Feb 25, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on February 25, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not cont
Cytosorbents Corp Files 8-K on Financials — Jan 13, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation F
Cytosorbents Corp Files 8-K — Jan 6, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on January 6, 2025, reporting other events and financial statements. The filing indicates a change in the company's status
Cytosorbents Corp Files 8-K on Financials — Jan 3, 2025 Risk: low
Cytosorbents Corporation filed an 8-K on January 3, 2025, reporting on its results of operations and financial condition. The filing includes financial statemen
Cytosorbents Corp Files 8-K — Dec 23, 2024 Risk: low
Cytosorbents Corporation filed an 8-K on December 23, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not c
Cytosorbents to be Acquired by Fresenius Medical Care for $107M — Dec 9, 2024 Risk: medium
Cytosorbents Corporation announced on December 9, 2024, that it has entered into a definitive agreement to be acquired by Fresenius Medical Care AG & Co. KGaA f
Cytosorbents Corp Files 8-K on Financials — Nov 7, 2024 Risk: low
Cytosorbents Corporation filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition, as well as financial statements and e
Cytosorbents Corp Files 8-K on Operations and Financials — Oct 1, 2024 Risk: low
Cytosorbents Corporation filed an 8-K on October 1, 2024, reporting on its results of operations and financial condition, as well as other events. The filing al
Cytosorbents Corp Enters Material Definitive Agreement — Aug 20, 2024 Risk: medium
Cytosorbents Corporation entered into a Material Definitive Agreement on August 16, 2024. The filing does not disclose specific details of the agreement, such a
Cytosorbents Appoints New CMO, Elects Director — Aug 16, 2024 Risk: low
Cytosorbents Corporation announced on August 13, 2024, the appointment of Dr. Phillip P. Chan as Chief Medical Officer and the election of Ms. Amy E. Smith to i
Cytosorbents Corp Files 8-K on Financials — Aug 14, 2024 Risk: low
Cytosorbents Corporation filed an 8-K on August 14, 2024, reporting on its results of operations and financial condition as of August 13, 2024. The filing detai
Cytosorbents Sells STARZ Business for Up to $100M — Aug 1, 2024 Risk: medium
Cytosorbents Corporation announced on July 26, 2024, that it has entered into a definitive agreement to sell its STARZ medical device business to an affiliate o
Cytosorbents Corp Files 8-K: Material Agreement & Other Events — Jul 5, 2024 Risk: medium
Cytosorbents Corporation entered into a Material Definitive Agreement on June 28, 2024, related to its business operations. The filing also includes other event
Cytosorbents Sets 2024 Annual Meeting Date — Jun 10, 2024 Risk: low
Cytosorbents Corporation announced on June 6, 2024, that it has scheduled its 2024 Annual Meeting of Stockholders for July 18, 2024. The meeting will include th
Cytosorbents Delists from Nasdaq, Moves to OTCQB — May 22, 2024 Risk: high
Cytosorbents Corporation filed an 8-K on May 22, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company's
Cytosorbents Corp Files 8-K on Financials — May 9, 2024 Risk: low
Cytosorbents Corporation filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition, and including financial statements and exh
Cytosorbents Corp Files 8-K for Bylaw Amendments & Financials — May 6, 2024 Risk: low
Cytosorbents Corporation filed an 8-K on May 2, 2024, reporting amendments to its articles of incorporation or bylaws and financial statements. The company, inc
Cytosorbents Appoints Dr. Vincent P. Cappello as CMO — Apr 3, 2024 Risk: low
Cytosorbents Corporation announced on March 29, 2024, the appointment of Dr. Vincent P. Cappello as Chief Medical Officer. Dr. Cappello previously served as the
Cytosorbents Corp Files 8-K on Financials — Mar 15, 2024 Risk: low
Cytosorbents Corporation filed an 8-K on March 15, 2024, reporting on its results of operations and financial condition as of March 14, 2024. The filing include
Cytosorbents Corp. Receives Delisting Notice — Jan 17, 2024
Cytosorbents Corporation filed an 8-K on January 17, 2024, indicating that it has received a notice of delisting or failure to satisfy a continued listing rule

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX